Health Care: Drugs

Allergan PLC (AGN: NYSE)

$331.15 2.28 | 0.69%
07/31/15 - 04:05 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 13.06B 8.68B 5.91B 4.58B
Cost of Sales 4.98B 4.20B 3.23B 2.47B
Gross Operating Profit 8.08B 4.48B 2.68B 2.11B
Selling, General, and Administrative Expenses 3.59B 2.05B 1.17B 754.90M
Research & Development 1.09B 616.90M 401.80M 295.40M
Operating Income before D & A (EBITDA) 3.40B 1.81B 1.11B 1.06B
Depreciation & Amortization 3.92B 1.33B 640.70M 447.90M
Interest Income 8.90M 4.80M 2.50M 2.10M
Other Income - Net -349.50M -235.40M 38.50M -79.20M
Special Income / Charges -441.60M -647.50M -149.50M 0.00
Total Income Before Interest Expenses (EBIT) -1.30B -398.60M 361.80M 537.80M
Interest Expense 411.80M 239.80M 116.70M 81.80M
Pre-Tax Income -1.71B -638.40M 245.10M 456.00M
Income Taxes -81.90M 112.70M 146.80M 196.90M
Minority Interest 300.00K -700.00K 1.00M -1.80M
Net Income From Continuing Operations -1.63B -751.10M 98.30M 259.10M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -1.63B -751.10M 98.30M 259.10M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -1.63B -750.40M 97.30M 260.90M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.19B -103.60M 247.80M 259.10M
Preferred Dividends
Net Income Available To Common -1.63B -751.10M 98.30M 259.10M
Basic EPS from Continuing Ops. -7.42 -5.27 0.77 2.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -7.42 -5.27 0.77 2.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -7.42 -5.27 0.77 2.10
Basic Normalized Net Income/Share -5.41 -0.73 1.95 2.10
EPS fr Continuing Ops. -7.42 -5.27 0.76 2.06
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -7.42 -5.27 0.76 2.06
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -7.42 -5.27 0.76 2.06
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-5.41 -0.73 1.91 2.06
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter